11 – 20 of 128
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Galectin-3 is upregulated in frontotemporal dementia patients with subtype specificity
- Contribution to journal › Article
-
Mark
Inflammatory bowel disease induces pathological α-synuclein aggregation in the human gut and brain
- Contribution to journal › Article
- 2023
-
Mark
Inhibition of the serine protease HtrA1 by SerpinE2 suggests an extracellular proteolytic pathway in the control of neural crest migration
- Contribution to journal › Article
-
Mark
Targeting galectin-3 to counteract spike-phase uncoupling of fast-spiking interneurons to gamma oscillations in Alzheimer’s disease
- Contribution to journal › Article
-
Mark
Cerebral Aβ deposition precedes reduced cerebrospinal fluid and serum Aβ42/Aβ40 ratios in the App NL−F/NL−F knock-in mouse model of Alzheimer’s disease
- Contribution to journal › Article
-
Mark
‘Proactive aging’ is a new research approach for a new era
- Contribution to journal › Letter
-
Mark
Maternal separation differentially modulates early pathology by sex in 5xFAD Alzheimer’s disease-transgenic mice
- Contribution to journal › Article
-
Mark
A comparison of machine learning approaches for the quantification of microglial cells in the brain of mice, rats and non-human primates
- Contribution to journal › Article
-
Mark
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
- Contribution to journal › Article
-
Mark
Add-on pramipexole for anhedonic depression : study protocol for a randomised controlled trial and open-label follow-up in Lund, Sweden
- Contribution to journal › Article
